Abstract
The Drug Safety and Effectiveness Network, promised by Prime Minister Stephen Harper in December 2007 and charged with the early identification of postmarket problems associated with prescription drugs, will be overseen by the Canadian Institutes of Health Research (CIHR). The network, which is
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
